Ailan Guo

This inventor holds 31 USPTO granted patents and 33 published patent applications, plus 1 CIPO patent and 11 EPO patents, primarily in Lung Cancer Research. Top assignees: Cell Signaling Technology, Inc., Bluefin Biomedicine, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ailan Guo. Retrieved from https://idiyas.com/inventor/ailan-guo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 33)

% Patents Active = 93.5

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 97(Granted Patents)

Location History:

Burlington, MA (US) (2010 - 2023)
Lexington, MA (US) (2012 - 2024)

Company Filing History:

29 out of 61

Cell Signaling Technology, Inc.

patents

2 out of 17

Bluefin Biomedicine, Inc.

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Antibodies

Lung Cancer

Mutant ALK

ROS Kinase

Ubiquitination

Phosphorylation

Tumor Detection

Drug Conjugates

NSCLC

Gene Defects

Caspase Motif

PDGFR-alpha

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577295 - MOTIF-SPECIFIC AND CONTEXT-INDEPENDENT ANTIBODIES THAT SPECIFICALLY BIND TO A SUMOYLATED LYSINE-CONTAINING RESIDUE (2026-03-17),

2. 12427163 - Anti-VTCN1 antibodies and antibody drug conjugates (2025-09-30),

3. 11932694 - Anti-VTCN1 antibodies and antibody drug conjugates (2024-03-19),

4. 11761005 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2023-09-19),

5. 11505833 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2022-11-22),

6. 11377486 - Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue (2022-07-05),

7. 11352418 - Analysis of ubiquitinated polypeptides (2022-06-07),

8. 11099188 - ROS kinase in lung cancer (2021-08-24),

9. 10955416 - Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer (2021-03-23),

10. 10889818 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2021-01-12),

11. 10870892 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2020-12-22),

12. 10526661 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2020-01-07),

13. 9988688 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2018-06-05),

14. 9856315 - Methylation and acetylation sites (2018-01-02),

15. 9523130 - Methods of treating non-small cell lung carcinoma (NSCLC) (2016-12-20),

Title: The Innovative Journey of Ailan Guo

Introduction: Ailan Guo, a talented inventor based in Lexington, MA, has made significant contributions to the field of technology and innovation.

Latest Patents: Ailan Guo's latest patents include groundbreaking inventions in the fields of artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, Ailan Guo has worked for top tech companies, leading research institutions, and universities, where he has spearheaded cutting-edge projects and received numerous accolades for his innovative work.

Collaborations: Ailan Guo has collaborated with renowned scientists, engineers, and researchers from around the world, fostering a culture of creativity and excellence in all his projects.

Conclusion: Ailan Guo's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.